Shuttle Pharmaceuticals Holdings, Inc.
Datakwaliteit: 83%
SHPH
Nasdaq
Manufacturing
Chemicals
€ 0,73
▼
€ 0,03
(-3,33%)
Marktkapitalisatie: 4,05 M
Prijs
€ 0,73
Marktkapitalisatie
4,05 M
Dagbereik
€ 0,70 — € 0,73
52-Weeksbereik
€ 0,50 — € 12,45
Volume
33.713
Openen € 0,70
50D / 200D Gem.
€ 1,19
38,84% below
50D / 200D Gem.
€ 2,58
71,93% below
Quick Summary
Belangrijkste Punten
Negative free cash flow of -9,48 M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-468,90%
Onder sectorgemiddelde (-51,02%)
ROIC-349,35%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio1,66
Interest CoverageN/A
Waardering
PE (TTM)
-0,35
Boven sectorgemiddelde (-1,98)
P/B Ratio2,91
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (44 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (44 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -0,4 | -2,0 |
| P/B | 2,9 | 5,1 |
| ROE % | -468,9 | -51,0 |
| Net Margin % | — | -150,2 |
| Rev Growth 5Y % | — | 9,3 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -11,72 M |
| ROE | -468,90% | ROA | -259,12% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -9,48 M |
| ROIC | -349,35% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1,66 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 1,30 M | Tangible Book Value | 1,39 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0,35 | Forward P/E | N/A |
| P/B Ratio | 2,91 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -233,87% | ||
| Market Cap | 4,05 M | Enterprise Value | 1,96 M |
| Per Share | |||
| EPS (Diluted TTM) | -7,16 | Revenue / Share | N/A |
| FCF / Share | -1,70 | OCF / Share | -1,70 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 80,89% |
| SBC-Adj. FCF | -10,27 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Net Income | -11,72 M | -9,14 M | -6,59 M | -3,03 M |
| EPS (Diluted) | -7,16 | -3,30 | -0,44 | — |
| Gross Profit | — | — | — | — |
| Operating Income | -11,92 M | -7,70 M | -5,89 M | -2,55 M |
| EBITDA | — | — | — | — |
| R&D Expenses | 4,05 M | 3,62 M | 3,52 M | 1,49 M |
| SG&A Expenses | — | — | — | — |
| D&A | 290.107,0 | — | — | — |
| Interest Expense | — | 100.000,0 | 2,12 M | 917.879,0 |
| Income Tax | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 10,48 M | 2,51 M | 5,95 M | 8,65 M |
| Total Liabilities | 8,22 M | 1,80 M | 1,90 M | 975.676,0 |
| Shareholders' Equity | 2,25 M | 709.152,0 | 4,06 M | 7,68 M |
| Total Debt | — | — | — | 91.021,0 |
| Cash & Equivalents | 334.005,0 | 1,92 M | 2,58 M | 8,42 M |
| Current Assets | 502.911,0 | 2,21 M | 5,59 M | 8,58 M |
| Current Liabilities | 7,97 M | 1,53 M | 1,04 M | 975.676,0 |
{"event":"ticker_viewed","properties":{"ticker":"SHPH","listing_kind":"stock","pathname":"/stocks/shph","exchange":"Nasdaq","country":"US"}}